These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cytotoxic activity and cytostatic mechanism of novel 2-arylbenzo[b]furans. Yang H; Pang JY; Cai YC; Xu ZL; Xian LJ J Pharm Pharmacol; 2006 Sep; 58(9):1281-7. PubMed ID: 16945188 [TBL] [Abstract][Full Text] [Related]
4. C1, a highly potent novel curcumin derivative, binds to tubulin, disrupts microtubule network and induces apoptosis. Srivastava S; Mishra S; Surolia A; Panda D Biosci Rep; 2016; 36(2):. PubMed ID: 26980197 [TBL] [Abstract][Full Text] [Related]
5. Development of Novel Bis(indolyl)-hydrazide-Hydrazone Derivatives as Potent Microtubule-Targeting Cytotoxic Agents against A549 Lung Cancer Cells. Das Mukherjee D; Kumar NM; Tantak MP; Das A; Ganguli A; Datta S; Kumar D; Chakrabarti G Biochemistry; 2016 May; 55(21):3020-35. PubMed ID: 27110637 [TBL] [Abstract][Full Text] [Related]
6. Cellular effects of curcumin on Plasmodium falciparum include disruption of microtubules. Chakrabarti R; Rawat PS; Cooke BM; Coppel RL; Patankar S PLoS One; 2013; 8(3):e57302. PubMed ID: 23505424 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents. Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271 [TBL] [Abstract][Full Text] [Related]
8. Triazole tethered C5-curcuminoid-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies. Singh H; Kumar M; Nepali K; Gupta MK; Saxena AK; Sharma S; Bedi PMS Eur J Med Chem; 2016 Jun; 116():102-115. PubMed ID: 27060762 [TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones. Aryapour H; Riazi GH; Ahmadian S; Foroumadi A; Mahdavi M; Emami S Pharm Biol; 2012 Dec; 50(12):1551-60. PubMed ID: 22984888 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, cytotoxicity, docking study, and tubulin polymerization inhibitory activity of novel 1-(3,4-dimethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxanilides. Aly OM; Beshr EA; Maklad RM; Mustafa M; Gamal-Eldeen AM Arch Pharm (Weinheim); 2014 Sep; 347(9):658-67. PubMed ID: 24996189 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and tubulin-binding properties of non-symmetrical click C5-curcuminoids. Caldarelli A; Penucchini E; Caprioglio D; Genazzani AA; Minassi A Bioorg Med Chem; 2013 Sep; 21(17):5510-7. PubMed ID: 23830698 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new symmetric curcumin derivatives. Sribalan R; Kirubavathi M; Banuppriya G; Padmini V Bioorg Med Chem Lett; 2015 Oct; 25(19):4282-6. PubMed ID: 26264500 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and mechanistic studies of curcumin analog-based oximes as potential anticancer agents. Qin HL; Leng J; Youssif BGM; Amjad MW; Raja MAG; Hussain MA; Hussain Z; Kazmi SN; Bukhari SNA Chem Biol Drug Des; 2017 Sep; 90(3):443-449. PubMed ID: 28186369 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker. Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]